Algenuity to act as an Industrial Partner within FP7 Project: TriForC

  • By algenuity
  • 31 Oct, 2013
Algenuity is to act as one of 5 SME industrial partners within the recently funded EU FP7 (Framework Programme 7) project,   TriForC (Triterpenoids For Commercialisation). Other partners include: University of Copenhagen (Denmark), John Innes Centre (UK), VIB (Belgium), the Weizmann Institute of Science (Israel), University of Thessaly (Greece), University of Piemonte (Italy), Alkion BioPharma (France), Extrasynthese (France), VivaCell Biotechnology (Spain), Stockton (Israel).
Share by: